Winton Group LTD Acer Therapeutics Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$1.53 - $4.53 $24,778 - $73,363	-16,195 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$1.18 - $5.86 $9,763 - $48,485	-8,274 Reduced 33.81%	16,195 $32,000
Q4 2019 Feb 13, 2020	SELL	$2.85 - $4.2 $3,194 - $4,708	-1,121 Reduced 4.38%	24,469 $98,000
Q3 2019 Nov 08, 2019	BUY	$1.95 - $3.93 $49,900 - $100,568	25,590 New	25,590 $82,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.